Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Limit PRN Psychotropic Medication Without Required Documentation

Goshen, Indiana Survey Completed on 05-23-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to limit the use of an as-needed (PRN) psychotropic medication, specifically lorazepam, to a 14-day duration without the required documentation for continued use for one resident. The resident, who had diagnoses including anxiety disorder and major depressive disorder and was noted to have severe cognitive impairment, received lorazepam on multiple occasions beyond the 14-day PRN limit. The medical record did not contain documentation from the prescribing practitioner justifying the continued use of lorazepam beyond the initial 14-day period, nor was there evidence of monitoring or rationale for the extended use in psychiatric progress notes. The care plan for the resident indicated the use of anti-anxiety medication related to his diagnoses, with interventions to assess anxiety and administer medication per physician order. However, interviews with staff confirmed that PRN psychotropic medications are limited to 14 days unless otherwise documented, and the facility's policy required physician documentation for any extension. Despite this, the resident continued to receive lorazepam without the necessary documentation or justification for its ongoing use.

An unhandled error has occurred. Reload 🗙